Grace Therapeutics Inc (GRCE) Stock Price, Quote, News & History

GRCENASDAQ
$2.45
0.010.41%
At close: Jul 10, 5:00 PM EST
$2.48
0.031.22%
After Hours: 9:25 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-8.87M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
3.71M
Free Cash Flow (TTM)
-8.87M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-5.16M

Analyst Trends and Forecast

1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$22.89M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.62
Earnings Yield % (TTM)
-19.18%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.93

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$16.98M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.47
Close
$2.45
Volume / Avg.
123.26K / 577.67K
Day Range
$2.37 - $2.52
52 Wk Range
1.79 - 5.18
Market Cap
$40.36M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
13.64%
Days to Cover
6.95

About

Sector
Health Care
Industry
Pharmaceuticals
Grace Therapeutics Inc is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its development pipeline consists of the following product candidates: GTx-104, a novel injectable formulation of nimodipine for the tr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Grace Therapeutics (GRCE) stock?

A

You can purchase shares of Grace Therapeutics (NASDAQ:GRCE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Grace Therapeutics (GRCE) competitors?

A

There are no as such competitors for Grace Therapeutics.

Q

What is the forecast, or price target, for Grace Therapeutics (GRCE) stock?

A

Grace Therapeutics has a consensus price target of $10.00.

Q

What is the current price for Grace Therapeutics (GRCE)?

A

The stock price for Grace Therapeutics (NASDAQ: GRCE) is $2.48 last updated July 10, 2026 at 9:25 AM EDT.

Q

Does Grace Therapeutics (GRCE) pay a dividend?

A

There are no upcoming dividends for Grace Therapeutics.

Q

When is Grace Therapeutics (NASDAQ:GRCE) reporting earnings?

A

Grace Therapeutics does not have any upcoming earnings scheduled.

Q

Is Grace Therapeutics (GRCE) going to split?

A

There is no upcoming split for Grace Therapeutics.

Q

What sector and industry does Grace Therapeutics (GRCE) operate in?

A

Grace Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.